Merit Financial Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Merit Financial Group's BSX Position: Q2 2026 in Review
Merit Financial Group reduced its Boston Scientific (BSX) stake by 3.3% in Q2 2026, selling an estimated $262K and leaving 142,932 shares worth $6.1M. The position accounts for 0.04% of the portfolio, ranked #375.
Merit Financial Group first reported a position in BSX in Q4 2019 and has held it in 17 quarters since. The position peaked at $14.5M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Merit Financial Group held 142,932 shares of Boston Scientific worth $6.1M as of Q2 2026.
- Merit Financial Group sold 4,830 Boston Scientific shares in Q2 2026, an estimated $262K.
- Boston Scientific made up 0.04% of Merit Financial Group's portfolio in Q2 2026, its #375 holding.
- Merit Financial Group first reported a position in Boston Scientific in Q4 2019 and has held it in 17 quarters since.
- Merit Financial Group's Boston Scientific position peaked at $14.5M in Q2 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.